Member views of the Network

 “It's difficult not to be affected by the burgeoning biotech industry. Ex-President Bill Clinton at last months BIO Conference in Chicago, said that two of biotechnologies main tasks in the immediate future will be to continue to improve food production and to come up with novel energy solutions. Fosters is deeply committed to the farm gate, the production of barley, the production of premium grapes. And as Bill has highlighted, to novel energy solutions from biotechnology.

The BioMelbourne Network provides Fosters with regular opportunities to tap into the biotech community, to policy makers, to be in the know, to pick up opportunities and to discuss common interests we can share with others.

BioMelbourne's great strength is its sense of place and time, its contacts with government, its resilient contacts with overseas cities and people of influence.”

Dr Peter Rogers, National Manager Research, Foster's Australia
 

"BioMelbourne provides a very important hub through which the local biotech companies interact with national and international healthcare industry professionals, service providers, investors and state politicians, and with each other.  It is an essential ingredient in fulfilling Melbourne’s ambitions to become one of the top global locations for life-science based industries.”

Dr Igor Gonda, Senior Biotech Executive.
 

“BioMelbourne Network delivers member cost savings that respond to industry needs. This is demonstrated by the range of competitive intelligence deals the Network has made available to members in the last 12 months, particularly the Thompson Pharma offer which was USD$25,000 below list price.”

Dr Tim Grogan, VP - Commercial Development & Licensing, Starpharma Ltd.
 

"As a newly established bioscience company, MG Nutritionals has benefited greatly from membership of BioMelbourne Network. The Network has provided unparalleled access to Melbourne's biotechnology community.

For MG Nutritionals, BioMelbourne Network has provided an excellent opportunity to network with a broad range of Government, commercial, and research organisations and benefit from shared understanding of interests, issues and capabilities."

Mr Peter Hobman, General Manager, Murray Goulburn Nutritionals.
 

"The BioMelbourne CEO Forum series provides an excellent opportunity to discuss relevant high level issues and to develop key peer relationships"

Dr Ashley Bates, Head of Discovery Research, GlaxoSmithKline.
 

"Avatar joined BioMelbourne Network in 2004 to support the development of the Victorian biotechnology industry, and to build constructive, long term relationships with Network members.

The Network delivers on both counts as Avatar has contributed funding and resources back to the industry in a meaningful fashion, our company has developed a broad customer base of Network members. At Avatar we are firm supporters of the Network and its objectives."

Mr Konrad Aerin, Director, Avatar Corporation.
 

"The BioMelbourne Network is undoubtedly Victoria's premier biotechnology networking and trade development organisation and it is also increasingly an access point to benefits like discounted services.  Its networking events attract all the key players in the industry and many fruitful relationships flow from its events.

Participation in the BioMelbourne Network is an extremely cost effective way to get industry recognition of involvement in the sector.  In particular, sponsorship of events allows for access to key decision makers in a very targetted way. BioMelbourne events and newsletters also provide an excellent way of keeping up to date with developments in the industry."

Ms Robyn Baker, Partner - National Head Life Sciences Group, Clayton Utz
 

“BioMelbourne Network not only provides members with a dynamic industry forum, it also delivers real cost savings such as reduced registration fees for international conferences and the Thomson Pharma deal which was a USD $25,000 reduction from list price.”

Dr James Campbell, Vice President of Operations, ChemGenex Pharmaceuticals Limited.
 

"Membership of the BioMelbourne Network provides great networking opportunities at its various events that are a great way for me to be updated on current activities and meet key players from the biotechnology scene.

CIMIT (Center for the Integration of Medicine and Innovative Technology), Boston and Bio21 Australia Ltd are developing a long term relationship.  We were delighted that through his BioBreakfast presentation, Dr Jonathan Rosen could showcase CIMIT activities to a broad audience from the Victorian biotechnology community.”

Dr Stella Clark, CEO, Bio21 Australia Ltd.
 

"BioMelbourne Network provides us with focussed access to industry participants and transactional opportunities. Together with its targeted sponsorship program, the Network has been an invaluable tool for building the Hindal Ventures life sciences practice."

Ms Natasha Mandie, Managing Director, Hindal Ventures Pty Ltd
 

"Thomson Scientific has been a member of the BioMelbourne Network for just over a year now and during that time have found the Network to be an excellent resource for us. In our view they are undoubtedly the premier Australian biotechnology network and have given us invaluable exposure to high level executives across the Biotechnology markets in Victoria resulting in us gaining some valuable new contacts, great exposure and not least sizeable new business."

Mr David Stammers, Business Development Manager, Thomson Scientific.
 

"I have found the networking and industry access opportunities provided by BioMelbourne Network to be very important in ensuring the on-going success of the CRC.  Staying in touch with the biotech community and exchanging the most up to date information through the breakfast seminars and CEO Luncheons have added much value to our activities.

The international trade missions led by BioMelbourne Network are highly focused and well organised. On a recent mission to BioPartnering Europe, it was clearly obvious that many opportunities arose through the reach and the credibility of the BioMelbourne Network.  I strongly recommend that any biotech organisation join the BioMelbourne Network to access these unique benefits."

Dr Glenn Tong, CEO, Molecular Plant Breeding CRC